asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 180 Volunteers with asthma poorly or partially controlled as defined by GINA (Global Initiative for Asthma); aged between 18 and 65; who had inhaled corticosteroid prescription for daily use by the attending physician.
Exclusion criteria
Exclusion criteria: Patients unable to use the inhaled drug due to motors or mental problems; with other lung diseases diagnosed or reported; who can not perform spirometry, unable to properly use the homemade or commercial spacers after watching educational film three times; patients who refuse to participate and sign the consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in score on a standardized questionnaire called the Asthma Control Test (ACT). The evaluations will be carried out before, thirty and sixty days after the start of medication. It is expected an increase of 3 or more points in this questionnaire.;Both groups showed a statistically significant change compared to basal values(p <0.001) 30 and 60 days after starting the experiment (beclomethasone spray aided by homemade spacer -Hm - or by commercial valved spacer - CV), with an increase of 7.0 and 7,8 points for the Hm group and 5.9 and 7.0 for the CV group (p = 0.261 between groups) respectively at days 30 and 60. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the Forced expiratory volume in the first second (FEV1) compared to basal values at 30 and 60 days evaluation;In the Hms group FEV1 increased from a Mean of 1,75 liter/second to 2,12 and 2,15 at days 30 and 60. in VCS group it rose from 1,86L/sec. to 2,19 and 2,21 at day 30 and 60, with difference from basal values but no difference between groups. | — |
Countries
Brazil
Contacts
Pos Graduação em Ciencias da Saúde da UFPE, Brasil